Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02812966 · ClinicalTrials.gov registry record · NA
Lutonix or Inpact for tHE tReatment Of fEmeropopliteal Stenosis - Drug Coated Balloon
A NA study, sponsored by Wake Forest University Health Sciences.
- Terminated
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT02812966 is a NA study that was terminated before completion, run by Wake Forest University Health Sciences. The registered enrollment target is 35 participants.
The verdict
NCT02812966, a NA study, was terminated before completion, sponsored by Wake Forest University Health Sciences.
- TERMINATED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
Investigators hypothesize in patients presenting with significant peripheral arterial disease with clinical indications for treatment with angioplasty, there will be a difference in 12 month patency between the subjects with Lutonix 035 Drug coated Balloon Percutaneous Transluminal Angioplasty Catheter and IN.PACT Admiral Paclitaxel-Coated Percutaneous Transluminal Angioplasty Balloon Catheter.
Interventions
- DEVICE Lutonix
- DEVICE IN.PACT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2016-04 |
| Est. Completion | 2019-12-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02812966
The ClinicalTrials.gov registry entry for NCT02812966 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Lutonix is the first listed.
NCT02812966 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02812966 about?
NCT02812966 is a clinical study titled "Lutonix or Inpact for tHE tReatment Of fEmeropopliteal Stenosis - Drug Coated Balloon". Investigators hypothesize in patients presenting with significant peripheral arterial disease with clinical indications for treatment with angioplasty, there will be a difference in 12 month patency between the subjects with Lutonix 035 Drug coated Balloon Percutaneous Transluminal Angioplasty Cathe...
What is the current status of trial NCT02812966?
This trial is currently terminated. It is a NA study. The enrollment target is 35 participants. The study started on 2016-04. Estimated completion is 2019-12-02.
What interventions are being tested in trial NCT02812966?
The interventions under investigation include: Lutonix (DEVICE), IN.PACT (DEVICE).
Who is sponsoring clinical trial NCT02812966?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.